Short answer
Innoviva, Inc. (INVA) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $120M (up 19.3% year over year) with net income of −$83M.
Q2 2026 key financials · XBRL
- Revenue
- $120M
- +19.3% YoY · +22.0% QoQ
- Net income
- −$83M
- −231.0% YoY · −144.7% QoQ
- Operating margin
- 42.5%
- Gross margin
- 75.8%
- EPS (diluted)
- −$0.97
- −199.0% YoY · −143.7% QoQ
Source: XBRL data from the Innoviva, Inc. (INVA) Q2 2026 10-Q on SEC EDGAR. USD.
Innoviva, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $119.6M, up 19% YoY from $100.3M
- Product sales $51.8M, up 46% YoY; XACDURO strongest growth at 46% overall
- Net royalty revenue $56.3M vs $63.9M YoY, down 12% amid U.S. pricing pressures
- Net loss $83.4M, driven by $161.0M unfavorable investment fair-value changes
- Cash $570.4M; Q2 share repurchases $31.4M and strategic portfolio commitments $55.0M
Risk Factors
- Risk Factors section not provided in submitted filing text
- Share-repurchase activity: 1,403,247 shares bought for $31.4 million during the quarter
- Capital-allocation risk: repurchases reduced remaining authorization to $68,595,263
- Debt risk: 2.125% convertible senior notes due 2028 disclosed as outstanding debt instrument
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Innoviva, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.